289 related articles for article (PubMed ID: 16308180)
1. Upper gastrointestinal haemorrhage complicating antiplatelet treatment with aspirin and/or clopidogrel: where we are now?
Liberopoulos EN; Elisaf MS; Tselepis AD; Archimandritis A; Kiskinis D; Cokkinos D; Mikhailidis DP
Platelets; 2006 Feb; 17(1):1-6. PubMed ID: 16308180
[TBL] [Abstract][Full Text] [Related]
2. A comparison of aspirin and clopidogrel with or without proton pump inhibitors for the secondary prevention of cardiovascular events in patients at high risk for gastrointestinal bleeding.
Hsiao FY; Tsai YW; Huang WF; Wen YW; Chen PF; Chang PY; Kuo KN
Clin Ther; 2009 Sep; 31(9):2038-47. PubMed ID: 19843493
[TBL] [Abstract][Full Text] [Related]
3. PPI use in patients commenced on clopidogrel: a retrospective cross-sectional evaluation.
Luinstra M; Naunton M; Peterson GM; Bereznicki L
J Clin Pharm Ther; 2010 Apr; 35(2):213-7. PubMed ID: 20456741
[TBL] [Abstract][Full Text] [Related]
4. Clopidogrel versus aspirin and esomeprazole to prevent recurrent ulcer bleeding.
Chan FK; Ching JY; Hung LC; Wong VW; Leung VK; Kung NN; Hui AJ; Wu JC; Leung WK; Lee VW; Lee KK; Lee YT; Lau JY; To KF; Chan HL; Chung SC; Sung JJ
N Engl J Med; 2005 Jan; 352(3):238-44. PubMed ID: 15659723
[TBL] [Abstract][Full Text] [Related]
5. Gastrointestinal bleeding in patients receiving a combination of aspirin, clopidogrel, and enoxaparin in acute coronary syndrome.
Ng FH; Wong SY; Lam KF; Chang CM; Lau YK; Chu WM; Wong BC
Am J Gastroenterol; 2008 Apr; 103(4):865-71. PubMed ID: 18177451
[TBL] [Abstract][Full Text] [Related]
6. Gastrointestinal bleeding after percutaneous coronary intervention.
Tanigawa T; Watanabe T; Nadatani Y; Otani K; Machida H; Okazaki H; Yamagami H; Watanabe K; Tominaga K; Fujiwara Y; Arakawa T
Digestion; 2011; 83(3):153-60. PubMed ID: 21266809
[TBL] [Abstract][Full Text] [Related]
7. Management of patients with high gastrointestinal risk on antiplatelet therapy.
Cryer B
Gastroenterol Clin North Am; 2009 Jun; 38(2):289-303. PubMed ID: 19446259
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of the antithrombotic effects of clopidogrel by proton pump inhibitors: facts or fancies?
Lettino M
Eur J Intern Med; 2010 Dec; 21(6):484-9. PubMed ID: 21111931
[TBL] [Abstract][Full Text] [Related]
9. Single antiplatelet therapy for patients with previous gastrointestinal bleeds.
Gellatly RM; Ackman ML
Ann Pharmacother; 2008 Jun; 42(6):836-40. PubMed ID: 18413689
[TBL] [Abstract][Full Text] [Related]
10. New look at antiplatelet agent-related peptic ulcer: an update of prevention and treatment.
Hsu PI
J Gastroenterol Hepatol; 2012 Apr; 27(4):654-61. PubMed ID: 22283743
[TBL] [Abstract][Full Text] [Related]
11. Upper gastrointestinal bleeding in patients receiving dual antiplatelet therapy after coronary stenting.
Yasuda H; Yamada M; Sawada S; Endo Y; Inoue K; Asano F; Takeyama Y; Yoshiba M
Intern Med; 2009; 48(19):1725-30. PubMed ID: 19797827
[TBL] [Abstract][Full Text] [Related]
12. Cardiovascular and gastrointestinal events of three antiplatelet therapies: clopidogrel, clopidogrel plus proton-pump inhibitors, and aspirin plus proton-pump inhibitors in patients with previous gastrointestinal bleeding.
Tsai YW; Wen YW; Huang WF; Chen PF; Kuo KN; Hsiao FY
J Gastroenterol; 2011 Jan; 46(1):39-45. PubMed ID: 20811753
[TBL] [Abstract][Full Text] [Related]
13. Risk and management of upper gastrointestinal bleeding associated with prolonged dual-antiplatelet therapy after percutaneous coronary intervention.
Tan VP; Yan BP; Kiernan TJ; Ajani AE
Cardiovasc Revasc Med; 2009; 10(1):36-44. PubMed ID: 19159853
[TBL] [Abstract][Full Text] [Related]
14. Combining aspirin and proton pump inhibitors: for whom the warning bell tolls?
Würtz M; Grove EL
Expert Opin Drug Metab Toxicol; 2012 Sep; 8(9):1051-5. PubMed ID: 22834712
[TBL] [Abstract][Full Text] [Related]
15. Bleeding risk associated with 1 year of dual antiplatelet therapy after percutaneous coronary intervention: Insights from the Clopidogrel for the Reduction of Events During Observation (CREDO) trial.
Aronow HD; Steinhubl SR; Brennan DM; Berger PB; Topol EJ;
Am Heart J; 2009 Feb; 157(2):369-74. PubMed ID: 19185647
[TBL] [Abstract][Full Text] [Related]
16. Significant gastrointestinal bleeding in patients at risk of coronary stent thrombosis.
Dai X; Makaryus AN; Makaryus JN; Jauhar R
Rev Cardiovasc Med; 2009; 10(1):14-24. PubMed ID: 19367228
[TBL] [Abstract][Full Text] [Related]
17. Upper gastrointestinal bleeding in patients with acute coronary syndromes: clinical predictors and prophylactic role of proton pump inhibitors.
Barada K; Karrowni W; Abdallah M; Shamseddeen W; Sharara AI; Dakik HA
J Clin Gastroenterol; 2008 Apr; 42(4):368-72. PubMed ID: 18277903
[TBL] [Abstract][Full Text] [Related]
18. The prevalence of co-administration of clopidogrel and proton pump inhibitors.
Shrestha K; Hughes JD; Lee YP; Parsons R
Qual Prim Care; 2011; 19(1):35-42. PubMed ID: 21703110
[TBL] [Abstract][Full Text] [Related]
19. Proton-pump inhibitors can decrease gastrointestinal bleeding after percutaneous coronary intervention.
Jiang Z; Wu H; Duan Z; Wang Z; Hu K; Ye F; Zhang Z
Clin Res Hepatol Gastroenterol; 2013 Dec; 37(6):636-41. PubMed ID: 23684576
[TBL] [Abstract][Full Text] [Related]
20. Analysis of gastrointestinal prophylaxis in patients receiving dual antiplatelet therapy with aspirin and clopidogrel.
Morneau KM; Reaves AB; Martin JB; Oliphant CS
J Manag Care Pharm; 2014 Feb; 20(2):187-93. PubMed ID: 24456320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
